missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-29/IFN-lambda 1 Protein
Click to view available options
Quantity:
50 μg
Unit Size:
50µg
Description
Measured in an anti-viral assay using HepG2 human hepatocellular carcinoma cells infected with encephalomyocarditis (EMC) virus. Sheppard, P. et al. (2003) Nat. Immunol. 4:63. The ED50 for this effect is 0.500-6.00 ng/mL.
Specifications
Specifications
| Accession Number | Q8IU54.1 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Gene ID (Entrez) | 282618 |
| Molecular Weight (g/mol) | M.W. Observed: 18-22 kDa, under reducing conditions., M.W. Theoretical: 20 kDa |
| Quantity | 50 μg |
| Source | E. coli-derived human IL-29/IFN-lambda 1 protein Pro23-Thr200 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Gene Alias | cytokine Zcyto21, IFNL1, IFN-lambda 1, IFN-lambda-1, IL29, IL-29, interferon lambda-1, interferon, lambda 1, interleukin 29 (interferon, lambda 1), interleukin-29, ZCYTO21 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction